Discover key trends in the US appendix cancer drugs market driven by R&D investments, biomarker-based therapies, and expanded clinical trials for rare gastrointestinal tumors https://www.openpr.com/news/4318370/united-states-appendix-cancer-drugs-market-advances-as-targeted